Curanex Pharmaceuticals share price logo

Curanex Pharmaceuticals Share Price

NASDAQ: CURX

Small Cap

$0.28

+0.02

(+6.34%)

as on

Curanex Pharmaceuticals Stock Performance

as on February 7, 2026 at 7:56 am IST

  • Day's Low

    Day's High

    $0.26
    $0.29
    downward going graph

    7.14%

    Downside

    3.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.26
    $9.18
    downward going graph

    6.43%

    Downside

    3178.43%

    Upside

    downward going graph

Curanex Pharmaceuticals share price movements today

Previous Close
$0.27
Open
$0.27
Volume
692.8K
Day's Low - High
$0.26 - $0.29
52 Week Low - High
$0.26 - $9.18

Curanex Pharmaceuticals Historical Returns

1 Month Return
-24.78 %
3 Month Return
-55.48 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Curanex Pharmaceuticals Stock Fundamentals & Key Indicators

Check Curanex Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-85.25%

Curanex Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Curanex Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Curanex Pharmaceuticals image
Curanex Pharmaceuticals
NA$9.5MNANA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$122.3B122.02%33.5631.35%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$47.7B98.75%1246.031.36%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.4BNA662.331.38%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.8B57.42%18.2832.13%

Curanex Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for Curanex Pharmaceuticals Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Curanex Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
-
Operating Income
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
Interest Expense
-
-
-
0
0
0
Depreciation
-
-
-
0
0
0
Income Before Tax
0
0
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
Net Income
0
0
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Curanex Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
-
Gross Profit
0
-
-
Operating Income
0
0
0
EBITDA
0
0
0
Interest Expense
-
-
-
Depreciation
0
0
-
Income Before Tax
0
0
0
Income Tax Expense
-
-
-
Net Income
0
0
0
Net Profit Margin
-77.82%
0.00%
0.00%

Curanex Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
0
0
0
0
0
Operating Cash Flow
0
0
0
0
-9
Investing Cash Flow
-
-
-
-
-
Financing Cash Flow
-
-
0
0
14
Change in Cash
0
0
0
0
5

Curanex Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
0
0
Operating Cash Flow
0
0
Investing Cash Flow
-
-
Financing Cash Flow
0
0
Change in Cash
0
0

Insights on Curanex Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CURX stock has moved down by -14.8%

About Curanex Pharmaceuticals

Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company. The Company is engaged in discovering, developing, and commercializing botanical drugs to treat patients suffering from inflammatory diseases and to develop therapies that offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections. Its lead candidate, Phyto-N, is a botanical extract from a single plant with anti-inflammatory properties that act via multiple targets and mechanisms. Its drug development pipelines encompass six various therapeutic areas: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, NAFLD, and gout. Phyto-N is being developed as an orally administered alternative for patients with moderate to severe ulcerative colitis, aiming to address limitations of current treatments. The Company's two botanical drugs include Veregen (sinecatechins) and Fulyzaq/Mytesi (crofelemer).
OrganisationCuranex Pharmaceuticals
Headquarters2 Jericho Plaza, Jericho, NY, United States, 11753
CEOMr. Jun Liu
E-voting on sharesClick here to vote

Key Management of Curanex Pharmaceuticals

Name

Title

Ms. Haiyan Yang

CFO & Treasurer

Dr. Liqin Xie Ph.D.

Chief Operating Officer

Dr. Ning Zhang Ph.D.

Chief Technology Officer

Dr. Huijuan Zhong Ph.D.

Chief Science Officer & Director

Mr. Jun Liu

CEO, President & Chairman

Ms. Dian Ying Jing

Secretary

FAQs

What is Curanex Pharmaceuticals share price today?

Curanex Pharmaceuticals share price today is $0.28 as on at the close of the market. Curanex Pharmaceuticals share today touched a day high of $0.29 and a low of $0.26.

What is the 52 week high and 52 week low for Curanex Pharmaceuticals share?

Curanex Pharmaceuticals share touched a 52 week high of $9.18 on and a 52 week low of $0.26 on . Curanex Pharmaceuticals stock price today i.e. is closed at $0.28,which is 96.95% down from its 52 week high and 6.87% up from its 52 week low.

What is Curanex Pharmaceuticals's market capitalisation today?

Curanex Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Curanex Pharmaceuticals Stock (CURX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Curanex Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Curanex Pharmaceuticals Shares that will get you 5.3571 shares as per Curanex Pharmaceuticals share price of $0.28 per share as on February 7, 2026 at 2:26 am IST.

What is the minimum amount required to buy Curanex Pharmaceuticals Stock (CURX) from India?

Indian investors can start investing in Curanex Pharmaceuticals (CURX) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Curanex Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Curanex Pharmaceuticals share’s latest price of $0.28 as on February 7, 2026 at 2:26 am IST, you will get 35.7143 shares of Curanex Pharmaceuticals. Learn more about fractional shares .